|
Academic/Biomedical Research
News & Jobs
|
|
|
|
|
|
|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Company Profiles
Research Store
Research Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
10/18/2012 9:15:45 AM
SOUTH SAN FRANCISCO, Calif., Oct. 17, 2012 (GLOBE NEWSWIRE) -- Hyperion Therapeutics, Inc. (Nasdaq:HPTX) announced today that the company will host and webcast an analyst and investor briefing on November 12, 2012, in Boston, MA at the 63rd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) or "The Liver Meeting®". The Hyperion Therapeutics analyst and investor briefing will take place from 6:30 p.m. – 7:30 p.m. Monday, November 12, 2012, in the Commonwealth Room of the Sheraton Hotel, connected to the Boston Hynes Convention Center.
|
|
|
|
|
|
|
|
|
|
|